Ultrasound and Somatosensory Median Nerve Evaluation in CRPS I
NCT ID: NCT06978608
Last Updated: 2025-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
50 participants
OBSERVATIONAL
2025-09-01
2026-02-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation by Clinical and Hand Ultrasound in Carpal Tunnel Syndrome
NCT07134361
Sonographic Follow-up of Patients With Carpal Tunnel Syndrome Undergoing Surgical or Conservative Treatment
NCT00694265
Does the Diacutaneous Fibrolysis Change Ultrasonographic Measurements in Patients With Carpal Tunnel Syndrome?
NCT04762238
Pre-operative Sonographic Assessment of The Median Nerve in Carpal Tunnel Syndrome. Does it Affect The Operative Procedure?
NCT03082027
Carpal Tunnel Syndrome: Case Reports and Analysis - Ultrasound Imaging and Pathomechanics of Median Nerve Compression
NCT00987571
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The participation of each participant in the study will be superimposed on the performance of the ultrasound and neuronographic examination; 50 patients will be enrolled at this hospital; the study will be conducted exclusively in the Careggi University Hospital. Each patient will be analysed by ultrasound and Neuronographic examination on both healthy and diseased side defining the morphological criteria and Neuronographic parameters of the median nerve based on the findings. The aim will be to try to define specific predictive morphological patterns.
Each patient will continue to be treated both diagnostically and therapeutically, as well as post-therapy monitoring, according to normal clinical practice.
Inclusion criteria
1. patients with a diagnosis of CRPS evaluated at the SOD of Hand Surgery and Reconstructive Microsurgery of the AOUC, Florence (IT)
2. Patients aged 18 years or older
3. Signature of informed consent to participation in the study and processing of related data
Exclusion criteria
1. patients with CRPS type II and therefore with known peripheral nerve injury
2. Patients under 18 years of age
Patients' clinical data (age, sex, treatment provided, clinical outcome) will be extracted from the medical records. Patients will be evaluated periodically on an outpatient basis according to the normal follow-up protocol.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Budapest Criteria positive for CRPS type I, older than 18 years old
Any specific symptoms will be recorded. Patients will undergo ultrasound examination to analyze on both the healthy and diseased side the morphological aspect of the median nerve at the carpal tunnel level, to address gliding in terms of mm, adhesion between the transverse ligament and flexor tendons. The aim will be to try to define specific predictive morphological patterns relative to the clinical appearance. Sensory nerve conduction velocity (SNCV) of the median-nerve will be evaluated to analyze the somatosensory part of the median nerve and understand the potential use of this as a diagnostic tool.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients aged 18 years and over
3. Signature of informed consent for participation in the study and processing of related data
Exclusion Criteria
2. Patients under 18 years of age
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliero-Universitaria Careggi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Rif CEAVC 28194
Identifier Type: REGISTRY
Identifier Source: secondary_id
Prot.: 0003733 del 2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.